MXL, COLM and SPSC Are Among After Hour Movers

Seeking AlphaApr 26 05:31

Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting

CAMBRIDGE, Mass., April 23, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (NASDAQ:OMGA) ("Omega"), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA

GlobeNewswireApr 23 19:00

CVAC, SBNY and CRMD Are Among After Hour Movers

Seeking AlphaApr 18 05:01

Omega Therapeutics (OMGA) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Yahoo FinanceApr 17 21:55

Omega Therapeutics CFO Joshua Reed to Depart

Seeking AlphaApr 17 04:47

Omega Therapeutics Presents New Preclinical Data Supporting The Potential Of Precision Epigenomic Control At AACR 2024

MYC-directed epigenomic controller exerts anti-tumor effect in preclinical models of EGFR inhibitor-resistant NSCLC regardless of underlying resistance mechanismValidation of novel translational assay

BenzingaApr 9 19:06